EPIQ Capital Group
VC Fund
San Francisco, United States
EPIQ Capital Group is a boutique multi-family office that serves a select group of ultra-high net worth clients and their families. EPIQ clients are given direct access to the investments and investing acumen that families of significant wealth deserve. It was founded in 2018 and is headquartered in San Francisco, California.
- Total investments:
- 24
- Last investment:
- Lead investor:
- 21%
Last updated:
For AI agents: llms.txt
Industries EPIQ Capital Group invests in
Stages EPIQ Capital Group invests in
Countries EPIQ Capital Group invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
|
|
|||
3 more contacts available
Investment Focus
Industry
- Biotechnology 7 (29%)
- Software 4 (17%)
- Therapeutics 4 (17%)
- Health Care 3 (13%)
- Machine Learning 3 (13%)
Stage
- Series B 8 (33%)
- Series C 4 (17%)
- Series A 3 (13%)
- Seed 1 (4%)
- Series D 1 (4%)
Country
- United States 15 (63%)
- Canada 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Chad Boeding
Founder / CEO
|
Founder / CEO | Total investments: 3 | Find email | |
|
Jennifer Forster
Partner
|
Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
AheadComputing is a company that specializes in designing, licensing, and providing support for high-performance microprocessor cores and related technologies. | $30M / Seed / Jan 21, 2026 | |
|
|
Swift Navigation was founded in 2012 to make GPS positioning technology more accurate and affordable. Today Swift Navigation has gained a reputation for defining a new category of GNSS systems as the industry’s first low-cost, high-accuracy real-time kinematics (RTK) receiver. Its GPS and GNSS positioning products are available at a fraction of theprice of the competition and deliver 100 times better accuracy than the GPS in a cell phone. Swift Navigation’s technology benefits a multitude of industries and applications—including autonomous vehicles, unmanned aerial vehicles (UAVs), precision agriculture, robotics, surveying, and space. With its innovation and technology honored by Inc.’s and Forbes 30 Under 30 lists, Swift Navigation is enabling a world where fields farm themselves, drones fly safely and autonomous transportation can take you home. Swift Navigation provides an end-to-end GNSS solution with a line of Piksi, Multi, and Duro / Duro Inertial receivers, Starling, Positioning Engine, and Skylark Cloud Corrections Service. | $50M / Series E / Jul 23, 2025 | |
|
|
AheadComputing is a company that specializes in designing, licensing, and providing support for high-performance microprocessor cores and related technologies. | $53.1M / Seed / Feb 19, 2025 | |
|
|
The leader in private AI. | $43M / Series A / Sep 10, 2024 | |
|
|
Zephyr AI is a high-growth healthcare technology company committed to radically reshaping traditional approaches to drug discovery and precision medicine. | $111M / Series A / Mar 13, 2024 | |
|
|
Tenstorrent is enabling a new era in AI and deep learning with its breakthrough processor architecture and software. The company’s mission is to deliver orders of performance and efficiency for AI workloads from the data center to the edge of the Cloud by co-designing hardware, software, and AI algorithms with their technology.Tenstorrent’sarchitecture scales from datacenter servers to IoT devices with improved efficiency, flexibility, programmability compared to legacy accelerators including CPUs, GPUs, FPGAs, and TPU-type processors. It is developed by their team with expertise in computer architecture, hardware design and verification, systems engineering, compilers, software development, and machine learning algorithms.Tenstorrent is backed by Venture Capital firms including Real Ventures and Eclipse Venture Capital, as well as prominent industry luminaries. | $100M / Convertible Note / Aug 02, 2023 | |
|
|
Swift Navigation was founded in 2012 to make GPS positioning technology more accurate and affordable. Today Swift Navigation has gained a reputation for defining a new category of GNSS systems as the industry’s first low-cost, high-accuracy real-time kinematics (RTK) receiver. Its GPS and GNSS positioning products are available at a fraction of theprice of the competition and deliver 100 times better accuracy than the GPS in a cell phone. Swift Navigation’s technology benefits a multitude of industries and applications—including autonomous vehicles, unmanned aerial vehicles (UAVs), precision agriculture, robotics, surveying, and space. With its innovation and technology honored by Inc.’s and Forbes 30 Under 30 lists, Swift Navigation is enabling a world where fields farm themselves, drones fly safely and autonomous transportation can take you home. Swift Navigation provides an end-to-end GNSS solution with a line of Piksi, Multi, and Duro / Duro Inertial receivers, Starling, Positioning Engine, and Skylark Cloud Corrections Service. | $100M / Series D / Oct 18, 2022 | |
|
|
Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The company's therapeutics are used to create next-generation programmable nucleases that can selectively target and edit cells, enabling physicians to treat their patient in an enhanced way. | $36.5M / Series B / Mar 22, 2022 | |
|
|
Epirus develops solid-state, software-defined directed energy systems for counter-electronics applications and power management in defense and commercial sectors. The company specializes in long-pulse high-power microwaves combined with AI and advanced electronics for electronic warfare. | $200M / Series C / Feb 15, 2022 | |
|
|
SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders. Its Gene Coding approach is guided by our Exact DNA Integration Technology (EDIT) platform, a genome engineering technology that leverages proprietary mammal-derived enzymes they call Saliogase. With broadapplicability, non-viral delivery capabilities of any size gene, and significant manufacturing advantages, EDIT has the potential to transform the treatment paradigm for inherited disorders and beyond. | $115M / Series B / Jan 05, 2022 | |
| See all 24 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does EPIQ Capital Group invest in?
EPIQ Capital Group invests primarily in Biotechnology, Software and Therapeutics startups, most often at Series B and Series C stage. Most of the 24 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact EPIQ Capital Group?
Public channels for EPIQ Capital Group include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at EPIQ Capital Group?
The team at EPIQ Capital Group includes Chad Boeding (Founder / CEO) and Jennifer Forster (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!